Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center.

Devanand D, Lee J, Luchsinger J, Manly J, Marder K, Mayeux R, Scarmeas N, Schupf N, Stern Y.

J Alzheimers Dis. 2013;33 Suppl 1:S447-55. Review.

2.

[Awareness disorders in Alzheimer's disease and in mild cognitive impairment].

Jacus JP, Dupont MP, Herades Y, Pelix C, Large H, Baud M.

Encephale. 2014 Apr;40(2):180-7. doi: 10.1016/j.encep.2013.10.003. Epub 2014 Mar 11. Review. French.

PMID:
24630532
3.

Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers.

Steenland K, Karnes C, Seals R, Carnevale C, Hermida A, Levey A.

J Alzheimers Dis. 2012;31(2):265-75. doi: 10.3233/JAD-2012-111922.

4.

Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.

Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, Schocke M.

J Alzheimers Dis. 2013;34(3):665-72. doi: 10.3233/JAD-122095.

PMID:
23254639
5.

Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.

Mangialasche F, Solomon A, Kåreholt I, Hooshmand B, Cecchetti R, Fratiglioni L, Soininen H, Laatikainen T, Mecocci P, Kivipelto M.

Exp Gerontol. 2013 Dec;48(12):1428-35. doi: 10.1016/j.exger.2013.09.006. Epub 2013 Oct 7.

PMID:
24113154
6.

NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.

Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES Jr, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M.

NIH Consens State Sci Statements. 2010 Apr 28;27(4):1-30. Review.

7.

Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.

Amieva H, Mokri H, Le Goff M, Meillon C, Jacqmin-Gadda H, Foubert-Samier A, Orgogozo JM, Stern Y, Dartigues JF.

Brain. 2014 Apr;137(Pt 4):1167-75. doi: 10.1093/brain/awu035. Epub 2014 Feb 27.

8.

Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment.

Buschert VC, Giegling I, Teipel SJ, Jolk S, Hampel H, Rujescu D, Buerger K.

J Clin Psychiatry. 2012 Dec;73(12):e1492-8. doi: 10.4088/JCP.11m07270.

PMID:
23290333
9.

Motivational reserve: motivation-related occupational abilities and risk of mild cognitive impairment and Alzheimer disease.

Forstmeier S, Maercker A, Maier W, van den Bussche H, Riedel-Heller S, Kaduszkiewicz H, Pentzek M, Weyerer S, Bickel H, Tebarth F, Luppa M, Wollny A, Wiese B, Wagner M; AgeCoDe Study Group.

Psychol Aging. 2012 Jun;27(2):353-63. doi: 10.1037/a0025117. Epub 2011 Aug 29.

PMID:
21875213
10.

Double compression: a vision for compressing morbidity and caregiving in dementia.

Cheng ST.

Gerontologist. 2014 Dec;54(6):901-8. doi: 10.1093/geront/gnu015. Epub 2014 Mar 11.

PMID:
24619219
11.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.); Alzheimer Association.

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Review. French.

PMID:
22579080
12.

[Alzheimer's disease].

Yilmaz U.

Radiologe. 2015 May;55(5):386-8. doi: 10.1007/s00117-014-2796-2. German.

PMID:
25957008
13.

Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.

Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, Hampel H, Jones RW, Kehoe P, Lenoir H, Minthon L, Olde Rikkert MG, Rodriguez G, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Verhey FR, Winblad B, Wahlund LO, Wilcock G, Visser PJ.

Dement Geriatr Cogn Disord. 2013;36(1-2):1-19. doi: 10.1159/000348354. Epub 2013 May 3.

PMID:
23651945
14.

A data-driven model of biomarker changes in sporadic Alzheimer's disease.

Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S, Schott JM, Alexander DC; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2014 Sep;137(Pt 9):2564-77. doi: 10.1093/brain/awu176. Epub 2014 Jul 9.

15.

Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease.

Sattler C, Toro P, Schönknecht P, Schröder J.

Psychiatry Res. 2012 Mar 30;196(1):90-5. doi: 10.1016/j.psychres.2011.11.012. Epub 2012 Mar 4.

PMID:
22390831
16.

Mediterranean diet and cognitive decline. A lesson from the whole-diet approach: what challenges lie ahead?

Solfrizzi V, Panza F.

J Alzheimers Dis. 2014;39(2):283-6. doi: 10.3233/JAD-130831.

PMID:
24270209
17.

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL; AIBL Research Group.

Brain. 2012 Jul;135(Pt 7):2126-39. doi: 10.1093/brain/aws125. Epub 2012 May 23.

18.

Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.

Julayanont P, Brousseau M, Chertkow H, Phillips N, Nasreddine ZS.

J Am Geriatr Soc. 2014 Apr;62(4):679-84. doi: 10.1111/jgs.12742. Epub 2014 Mar 17.

PMID:
24635004
19.

Risk of progression from mild memory impairment to clinically diagnosable Alzheimer's disease in a Japanese community (from the Nakayama Study).

Sonobe N, Hata R, Ishikawa T, Sonobe K, Matsumoto T, Toyota Y, Mori T, Fukuhara R, Komori K, Ueno S, Tanimukai S, Ikeda M.

Int Psychogeriatr. 2011 Jun;23(5):772-9. doi: 10.1017/S104161021000222X. Epub 2010 Dec 16.

PMID:
21205364
20.

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.

Lim YY, Maruff P, Pietrzak RH, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC; AIBL Research Group.

Brain. 2014 Jan;137(Pt 1):221-31. doi: 10.1093/brain/awt286. Epub 2013 Oct 30.

Items per page

Supplemental Content

Write to the Help Desk